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ABSTRACT
Introduction and Objectives: Clinical and functional as-
sessment comparing cases of full-thickness chondral defects 
(OC) treated with mosaicplasty or mosaicplasty covered 
with periosteum (mosaicambium). Methods: 20 knees with 
chondral defect, (10 mosaicplasty/10 mosaicambium) were 
operated between 1999 and 2005. All patients were clinically 
assessed preoperatively using the ICRS scale, VAS scale, X-ray 
and MRI. During 2008, we reviewed patients using the same 
protocol. For statistical purposes, the patients were divided 
into two groups, according to the surgical technique. Statis-
tical analysis was performed with EPI2000 program, using 
chi-squared test and Student’s t test, with a significance level 
of 0.05. Results: Preoperatively, all patients were in group C 
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/D (ICRS scale). In 2008, 18 cases were in groups A and B 
according to the ICRS scale (12 in A). Between groups, there 
were no statistical differences. The X-ray study revealed no 
changes in 55% of cases. Discussion: With no differences, 
why mosaicambium option? Morbidity on graft donor zones 
is not negligible. Mosaicambium uses less chondral grafts, 
reducing the potential for morbidity at graft donor zones. 
Conclusion: The mosaicambium technique is an excellent 
alternative for chondral defects greater than 2 cm2.
“…articular cartilage defects are a troublesome thing…
they don’t heal…”.William Hunter (1718-1783).
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INTRODUCTION
There are several forms of treatment of symptom-
atic osteochondral defects, such as drilling(1), mi-
crofractures(2), covering with periosteum(3,4), trans-
position of cartilage from areas of lower demand(5), 
mosaicplasty(6), or autologous chondrocytes(7,8).
Since 1999, the author has been using a mixed 
technique utilizing mosaicplasty covered with peri-
osteum (cambium layer) for osteochondral substance 
losses greater than 2 cm2. This paper aims to pres-
ent the technique and evaluate the clinical results 
obtained.
METHODS
Between 1999 and 2005, 20 patients with more 
than 2 cm2 loss of osteochondral (OC) substance at 
the femoral condyles were treated in our clinic. In 
10 patients we used the classical mosaicplasty tech-
nique described by Hangody et al.(9). In the remaining 
10, we used a technique developed by the author, the 
object of presentation in an international meeting(2), 
called “mosaicambium”. Patients were only admit-
ted for inclusion in this review if they had lost more 
than 2 cm2 of OC substance in the knee, and whose 
opposite knee never had any symptoms and/or under-
gone any surgery. We excluded all bilateral cases, in 
order to use the opposite knee as the standard. The 
procedure to be adopted was chosen at random by 
procedure alternation (mosaicplasty/mosaicambium), 
according to the date of admission into the clinic.
Patients were operated under general or locore-
gional anesthesia. The protocol procedure presup-
posed prior arthroscopy to confirm the type and ex-
tent of the injury. Subsequently, reconstruction of the 
surface by mosaicambium or mosaicplasty was per-
formed through mini-arthrotomy. Osteochondral au-
tografts cylinders with diameters between 2.7 and 3.5 
mm and a length of 20 mm were harvested for both 
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Figure 1 – Schematic of the technique.
Figure 2A – Osteochondral grafts.
Figure 2B – Coating with periosteum.
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techniques, preferably in the medial femoral condyle 
in the intercondylar area of the same knee using the 
mosaicplasty system (Smith & Nephew Endoscopy). 
The harvested grafts were implanted in the area of the 
osteochondral defect following the precepts described 
by Hangody et al.(9).
For the mosaicambium technique, the osteochon-
dral cylinders were then covered with periosteal grafts 
harvested from the tibia, with the “cambium” side fa-
cing the implanted cylinders. The graft was fixed with 
resorbable sutures (Figure 1 and Figures 2A and 2B).
Postoperatively, the same protocol was used for all 
cases, the principles of which were exercises of joint 
mobilization and muscle strengthening. The rehabilita-
tion program places special emphasis on gaining range 
of motion. Walking without weight-bearing is allowed 
as early as 48 hours, and walking bearing their full 
weight is allowed between the 7th and 10th weeks.
The preoperative evaluation protocol provides, 
besides history, an assessment of the range of mo-
tion, the presence/absence of intra-articular effusion, 
tender points, meniscal signals, and signs of ligament 
instability. Later, the protocol1 of the International 
Cartilage Research Society (ICRS) is used, which 
includes information on the cause of the injury, the 
onset of symptoms, sports activities, the patient’s age 
at the time of trauma, subjective assessment of the 
functioning of the knee (as a percentage relative to 
the opposite knee) and level of physical activity. This 
classification shows good reliability and is accurate 
between its final result and the state of the cartilage 
observed in arthroscopy(10). The depth and degree of 
impairment of the cartilage were also assessed on a 
scale of four grades(11).
The data collected allow us to group patients into 
four levels, with A being the best and D the worst. 
The final grade corresponds to the worst recording 
of all items assessed.
A visual analogue scale (VAS) for pain was ad-
opted, giving the patient a ruler with 100 mm, marked 
from 0 to 10 in intervals of 10 mm, where 0 corre-
sponded to no pain and 10 to unbearable pain. The 
patient was asked to indicate the exact point at which 
Site preparation Implantation of grafts Periosteum placement
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1 The cartilage standard evaluation form/knee. ICRS Newsletter, Spring 1992.
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they would consider their pain. The recorded value 
was measured in mm from the 0 point.
Radiography followed the clinic’s usual protocol, 
including radiographs frontal and lateral to the knee, 
and axial to the hinges in 30° of flexion. The evalu-
ation adopted the ICRS scale protocol using four 
grades according to existing degenerative changes 
(no change, femorotibial (FT) interline narrowing less 
than 50%, FT interline narrowing greater than 50%, 
narrowing of the interline with any other degenera-
tive change present). This classification is particularly 
useful for evaluating the medium and long-term, par-
ticularly in the presence of degenerative changes.
The MRI evaluation was only performed routinely 
in the preoperative period from 2004 and in the revi-
sion evaluation.
When 12 months from surgery were completed, 
patients were asked in a non-compulsory manner, to 
undergo a second-look evaluation performed by ar-
throscopy. Only 10 patients accepted.
The null hypothesis (Ho) was the absence of clini-
cal differences between patients operated with mosa-
icplasty and patients operated with mosaicambium. 
The opposite knee was considered the standard.
The results were analyzed with the EPI2000 statis-
tical program, using the chi-square test for categorical 
variables and Student’s t-test for continuous variables. 
P values < 0.05 were considered significant.
RESULTS
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is described in Table 1.
There was a predominance of male patients (70%), 
with a mean age of 26.5 ± 5.5 years at surgery. In the 
overwhelming majority of cases, the medial condyle 
was affected. The average size of the area of OC loss 
was 2.59 ± 0.2 cm. When preoperatively evaluating 
the VAS, the mean value was 80 ± 15 mm. In the to-
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cant difference between the groups (p > 0.05).
The number of cylinders used is described in Table 2, 
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inders used in cases of mosaicambium (p = 0.001). In 
the review conducted in 2008, the average follow-up 
period was 5.9 ± 1.6 years (minimum of three years 
and a maximum of nine years).
The detailed final evaluation of patients can be ob-
served in Table 3. Despite the different distributions, 
the p value was not significant (p = 0.44).
The intensity of pain in 2008 showed a mean of 
5.9 ± 1.6 on the VAS scale, a value much lower than 
the preoperative period, but still higher than that of 
the opposite knee, whose value was 0 in all cases. The 
comparison of data between the mosaicplasty group 
and the mosaicambium group showed no statistical 
difference.
Radiographically, nine patients (45.0%) showed 
degenerative changes, eight of which were in group II 
and one of which was in group III of the ICRS clas-
sification, without statistically significant differences 
between groups.
On MRI, 73.4% of patients showed changes, not 
only of cartilage irregularity, but also with the presen-
ce of signal changes at the OC cylinder donor site. 
However, in cases treated with mosaicambium, the 
joint line of the cartilage appeared more regular than 
in those undergoing simple mosaicplasty, as shown 
in Figure 3, which illustrates a case with four years 
of evolution.
With the second-look evaluation, changes in the 
cartilage were observed in all of the cases reviewed, 
but, similarly to the MRI, the presence of cartilage 
irregularities was lower in patients in whom the mo-
saicambium technique was used (Figures 4A and 4B).
Figure 3 – Control with four years of evolution.
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Figure 4A – Arthroscopic control of a patient with mosaicambium.
Figure 4B – Arthroscopic control of a patient with mosaicplasty.
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Table 1 – Profile of patients evaluated.
Case Gender Age Condyle Size (cm2) Cause
Symptom 
onset
Pre-op 
ICRS 
Surgical technique
X-rays – ICRS
Final ICRS 
Pre-op Revision
1 Male 31 Medial 2.5 ADL Gradual IV Mosaicplasty II II II
2 Male 18 Lateral 2.5 Sports Gradual III Mosaicambium I I I
3 Male 33 Medial 2 ADL Acute III Mosaicplasty I II I
4 Male 33 Medial 3 ADL Gradual IV Mosaicambium I II II
5 Male 37 Medial 2.5 ADL Gradual IV Mosaicplasty I I I
6 Male 18 Medial 2.5 Sports Gradual IV Mosaicambium I I I
7 Male 21 Medial 2.9 Sports Acute IV Mosaicplasty I I II
8 Male 23 Medial 2.9 ADL Gradual IV Mosaicambium I II IV
9 Male 21 Medial 2.8 ADL Gradual III Mosaicplasty I I II
10 Male 30 Medial 2.5 ADL Gradual III Mosaicambium I II I
11 Male 26 Lateral 2.5 ADL Acute III Mosaicplasty I I I
12 Male 25 Medial 2.5 ADL Gradual IV Mosaicambium I I I
13 Male 26 Medial 2.6 Sports Acute IV Mosaicplasty I II I
14 Male 28 Medial 2.6 ADL Gradual IV Mosaicambium I I II
15 Male 28 Medial 2.6 ADL Gradual IV Mosaicplasty II II II
16 Male 25 Medial 2.5 Sports Acute IV Mosaicambium I II I
17 Male 22 Medial 2.5 Sports Acute III Mosaicplasty I I I
18 Male 20 Medial 2.5 ADL Gradual III Mosaicambium II III III
19 Male 31 Medial 2.7 ADL Gradual III Mosaicplasty I I I
20 Male 33 Medial 2.7 ADL Gradual III Mosaicambium I I I
Table 2 – Profile of patients evaluated (II).
Case Surgical technique No. of cylinders
1 Mosaicplasty 3
2 Mosaicambium 2
3 Mosaicplasty 3
4 Mosaicambium 4
5 Mosaicplasty 3
6 Mosaicambium 2
7 Mosaicplasty 3
8 Mosaicambium 2
9 Mosaicplasty 3
10 Mosaicambium 2
11 Mosaicplasty 4
12 Mosaicambium 2
13 Mosaicplasty 4
14 Mosaicambium 2
15 Mosaicplasty 3
16 Mosaicambium 4
17 Mosaicplasty 3
18 Mosaicambium 3
19 Mosaicplasty 3
20 Mosaicambium 2
Table 3 – Final evaluation according to the ICRS scale.
Final ICRS evaluation Class I Class II Class III Class IV
Mosaicplasty 6 4 – –
Mosaicambium 6 2 1 1
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Figure 5 – Arthroscopic control at the osteochondral graft harvest site.
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DISCUSSION
There are many different causes of cartilage pa-
thology. Isolated changes in cartilage, though often 
asymptomatic, are very common, often prompting 
an arthroscopic discovery(12). The various treatment 
techniques available can be divided into three catego-
ries: techniques that stimulate fibrocartilage-forming 
bone marrow, cartilage regeneration techniques, os-
teocartilaginous graft transposition or transplantation 
techniques.
In this last category are the techniques of pe-
riosteum grafts(3), osteochondral auto-or allografts, 
mosaicplasty, or mosaicambium. Mosaicplasty has 
become a very popular option since its development 
and dissemination by Hangody et al.(13,14), in which 
osteocartilaginous cylinders are harvested from non-
load-bearing areas(15) and placed in the site of the 
osteocartilaginous defect, covering about 70% of 
the area(13,14). This value is provided without any 
apparent scientific evidence to support it. Bussiere 
et al.(16) proposed a mathematical formula for calcu-
lating the area that should be replaced, but showed 
no clinical evidence of this formula being correct. 
Another issue raised in mosaicplasty is the type of 
cartilage that sits between the donor areas, which is 
often fibrocartilage(14,16). Finally, it should be noted 
that in mosaicplasty there may be residual pain and 
functional impairment of the knee due to sequelae at 
the donor site, as reported by Bobic(15) and Ahmad 
et al.(17) (Figure 5).
In the area close to the bone, the periosteum has the 
so-called cambium layer, which has undifferentiated 
cells capable of differentiating, in an intra-articular 
medium, into chondrocytes to produce hyaline carti-
lage(3). This ability has led some authors to use it as an 
important matrix in tissue engineering in vitro in the 
production of cartilage(18,19). The use of periosteum 
in isolation has led to poor results(20) and was the-
refore abandoned. However, in cases of autologous 
chondrocyte transplantation, it is necessary to use the 
periosteum cambium layer as a means of restraining 
and stimulating the production of cartilage(7).
Due to the recognition of the possible consequences 
of the mosaicplasty when a large number of cylin-
ders is harvested, combined with the impossibility 
of using autologous chondrocyte transplantation in 
a hospital, we have developed and used a technique 
combining mosaicplasty covered with periosteum in 
cases of patients with osteochondral defects greater 
than 2 cm2. We can reduce the number of cylinders 
used with this technique, while we resort to the in-
ner layer (cambium layer) of the periosteum with a 
source for the differentiation of chondrocytes. In ad-
dition to this advantage, the possibility of bringing a 
well-shaped layer on the surface of the condyle that 
closely resembles its original form could limit the ir-
regularity of the articular surface that is commonly 
seen in cases of mosaicplasty.
In this study, clinical outcomes were not different 
from those obtained with mosaicplasty, with a clear 
improvement in the pre-surgical state. Using the op-
posite knee as the standard, in either case (mosaicam-
bium or mosaicplasty), the results fell short of the 
normal standard, which is understood and accepted. 
The smaller number of osteochondral cylinders used 
is in accordance with one of the objectives of the mo-
saicambium technique, which a strong point to be 
highlighted.
In those cases that underwent an arthroscopic sec-
ond-look, the fact that it was only conducted in cases 
that volunteered to do so, which were not all cases, 
creates a possible information bias. Notice, however, 
that the quality of the cartilage and regularity of the 
articular surface seen in arthroscopy seemed to be 
better in cases of mosaicambium (Figure 4A) than 
in the mosaicplasty (Figure 4B). However, the small 
number of cases evaluated does not permit any de-
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essary. The fact that we are facing a more aggressive 
procedure poses ethical and deontological problems 
MOSAICPLASTY WITH PERIOSTEAL GRAFT FOR RESURFACING LOCAL FULL-THICKNESS 
CHONDRAL DEFECTS OF THE KNEE
158
 1.  Fritz J, Janssen P, Gaissmaier C, Schewe B, Weise K. Articular cartilage defects 
in the knee- basics, therapies and results. Injury. 2008;39(Suppl 1):S50-7.
 2.  Rodrigo JJ, Steadman JR, Silliman JF, Fulstone HA. Improvement of full-thick-
ness chondral defect healing in the human knee after debridement and micro-
fracture using continuous passive motion. Am J Knee Surg. 1994;7:109-16.
 3.  O’Driscoll SW, Recklies AD, Poole AR. Chondrogenesis in periosteal explants. An 
organ culture model for in vitro study. J Bone Joint Surg Am. 1994;76(7):1042-51.
 4.  Simon TM, Van Sickle DC, Kunishima DH, Jackson DW. Cambium cell stimulation 
from surgical release of the periosteum. J Orthop Res. 2003;21(3):470-80.
 5.  Outerbridge HK, Outerbridge RE, Smith DE. Osteochondral defects in the knee. A 
treatment using lateral patella autografts. Clin Orthop Relat Res. 2000;(377):141-51.
 6.  Hangody L, Kish G, Karpati Z, Szerb I, Udvarhelyi I. Arthroscopic autogenous os-
teochondral mosaicplasty for the treatment of femoral condylar articular defects. 
A preliminary report. Knee Surg Sports Traumatol Arthrosc. 1997;5(4):262-7.
 7.  Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment 
of deep cartilage defects in the knee with autologous chondrocyte transplanta-
tion. N Engl J Med. 1994;331(14):889-95.
 8.  Rosenberger RE, Gomoll AH, Bryant T, Minas T. Repair of large chondral defects 
of the knee with autologous chondrocyte implantation in patients 45 years or 
older. Am J Sports Med. 2008;36(12):2336-44.
 9.  Hangody L, Feczko P, Bartha L, Bodo G, Kish G. Mosaicplasty for the treatment 
of articular defects of the knee and ankle. Clin Orthop Relat Res. 2001;(391 
Suppl):S328-36
10.  Smith GD, Taylor J, Almqvist KF, Erggelet C, Knutsen G, Garcia Portabella M, 
et al. Arthroscopic assessment of cartilage repair: a validation study of 2 scoring 
systems. Arthroscopy. 2005;2(12):1462-7.
11.  Makino A, Muscolo DL, Puiegdevall M, Costa-Paz M, Ayerza M. Arthroscopic fixa-
tion of osteochondritis dissecans of the knee: clinical, magnetic resonance ima-
ging, and arthroscopic follow-up. Am J Sports Med .2005;33(10):1499-504.
12.  Årøen A, Løken S, Heir S, Alvik E, Ekeland A, Granlund OG, et al. Articular cartilage 
lesions in 993 consecutive knee arthroscopies. Am J Sports Med. 2004;32(1):211-5.
13.  Hangody L, Feczko P, Bartha L, Bodo G, Kish G. Mosaicplasty for the treatment 
of articular defects of the knee and ankle. Clin Orthop Relat Res. 2001;(391 
Suppl):S328-36.
14.  Hangody L, Kish G, Karpati Z, Udvarhelyi I, Szigeti I, Bely M. Mosaicplasty 
for the treatment of articular cartilage defects application in clinical practice. 
Orthopaedics. 1998;21(7):751-6.
15.  Bobic V. Arthroscopic osteochondral auto graft transplantation in anterior cru-
ciate ligament reconstruction: a preliminary clinical study. Knee Surg Sports 
Traumatol Arthrosc. 1996;3(4):262-4.
16.  Bussiere C, Selmi TAS, Neyret PH, Francisco LNFL, Prado RK. Osteochondral mo-
saicplasty. Twenty-two clinical cases. Rev Port Ortop Trauma. 2006;14(2):1-21.
17.  Ahmad CS, Guiney WB, Drinkwater CJ. Evaluation of donor site intrinsic he-
aling response in autologous osteochondral graft of the knee. Arthroscopy. 
2002;18(1):95-8.
18.  Haasper C, Zeichen J, Meister R, Krettek C, Jagodzinski M. Tissue engineering 
of osteochondral constructs in vitro using bioreactors. Injury. 2008;39(Suppl 1):
S66-76.
19.  Zhang X, Awad HA, O’Keefe RJ, Guldberg RE, Schwarz EM. A perspective: 
engineering periosteum for structural bone graft healing. Clin Orthop Relat Res. 
2008;466(8):1777-87.
20.  Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review 
of the current status and prospects. Osteoarthritis Cartilage. 2002;10(6):432-63.
21.  Ramappa AJ, Gill TJ, Bradford CH, Ho CP, Steadman JR. Magnetic resonance 
imaging to assess knee cartilage repair tissue after microfracure of chondral 
defects. J Knee Surg. 2007;20(3):228-34.
22.  Kreuz PC, Steinwachs M, Erggelet C, Krause SJ, Ossendorf C, Maier D, et 
al. Classification of graft hypertrophy after autologous chondrocyte implan-
tation of full-thickness chondral defects in the knee. Osteoarthritis Cartilage. 
2007;15(12):1339-47.
REFERENCES
Rev Bras Ortop. 2009;44(2):153-8
that can only be solved when MRI assessment tech-
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today for similar situations(21).
Why choose this new procedure, taking into ac-
count the existence of another that is well-studied 
and standardized? The main reason is the decrease in 
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loss, reducing the potential morbidity of the donor 
areas(15) and avoiding the need to harvest a graft in 
other joints or near the patellofemoral joint, a site of 
proven residual morbidity, with presence of patello-
femoral pain(17). The present work demonstrates that 
the clinical results obtained with the mosaicambium 
technique were not inferior to the standard technique 
A<&.*,7$(*.+2B8# 7&-'%<,-/# +!"# !2$&+!".,.C# 6,-7"#
fewer grafts are harvested with the mosaicambium 
technique than the standard technique, the likelihood 
of reducing morbidity associated with donor sites is 
greater, wherein resides its principal advantage.
Assessing the quality of the cartilage obtained was 
not an objective of the work, taking into account the 
constraints mentioned. In the few cases of second-
look evaluation, the cartilage had a hyaline appear-
ance and the hypertrophy phenomena described in 
autologous chondrocyte transplantation were not ob-
served(23), although the small number of cases limits 
the quality of information.
In any case, the mosaicambium technique should be 
considered as an alternative with reliable clinical results.
CONCLUSION
The mosaicambium technique is an option to con-
sider whenever there is more than 2 cm2 loss of OC 
substance, due to the lower number of grafts needed 
and the decreased morbidity related to the donor site.
